We conducted a case-control study in five general hospitals in the region of Antwerp, studying 161 patients (102 men, 59 women) and hospital control subjects matched for age and sex to explore the relation between drug use and upper gastrointestinal bleeding from 'erosive lesions' (peptic oesophagitis, gastric erosions, gastric ulcer(s), or duodenal ulcer(s)).
Although the relation between upper gastrointestinal bleeding from peptic ulcers (and, in some studies, gastric erosions) and the use of non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin has been extensively studied.'-" the number of well performed casecontrol studies dealing with this subject is limited.`Some of these case-control studies concern only aspirin (and paracetamol)3 while others comprise only a small number of patients.7 To There was no significant difference between cases and control subjects in the use of tobacco, alcohol, paracetamol, corticosteroids, diuretics, B blocking drugs, other antihypertensives, antianginous drugs, cardiac glycosides, bronchodilators, antibiotics, psychotropic drugs, and oral anticoagulants (Table I ). There was, however, a highly significant difference in the use of NSAIDs (odds ratio 7-4, p<0 001; 95% confidence interval odds ratio 3-7 to 14-7) and a significant difference in the use of aspirin (odds ratio 2-2, p=0 025; 95% CI odds ratio 1-3 to 4 0) (Table II) . There also was a highly significant difference between cases and control subjects regarding the presence of antecedents of peptic ulcer disease (odds ratio 5.5, p<0C001; 95% CI odds ratio 3-2 to 9-6) ( Table II) .
When odds ratios for NSAID use were calculated separately for each source of bleeding and for sex (Table III) women and for duodenal ulcer(s) in men; the odds ratio for gastric ulcer(s) in men approached significance (p=010) ( Table III) . Odds ratios for people aged 60 or younger and over 60 were compared (Table III) , and were highly significant in the older age group (p<0001), whereas although the difference in younger patients was less significant it was clearly significant (p=0 025). When patients were grouped according to age and sex, significance was highest in older women and men, respectively; the difference was less significant in younger men and not found in younger women, probably because of the small number ofpatients in that group (Table  III) . When calculations for these different subgroups were repeated for aspirin use (Table IV) only the odds ratio for women was significant; none of the other odds ratios was significant, although they approached significance in older people and both older and younger women (p=0 10). Twelve patients were using both NSAIDs and aspirin; the source of bleeding in these patients was duodenal ulcer(s) in six, gastric ulcer(s) in four, gastric erosions in one, Patients with upper gastrointestinal bleeding from 'erosive' lesions associated with NSAID use were older than patients who were non-users of NSAIDs, and in the user group both sexes were equally represented, whereas in non-users there was an important male predominance. This has been a feature of several other studies6 1314 and probably reflects prescribing habits. Another striking finding was the difference in outcome for NSAID users, whereas there was no significant difference in transfusion requirements or need for surgery. In some studies concerning NSAID use and upper gastrointestinal bleeding no difference was found in the need for surgical treatment or in mortality,'4 whereas in others a significant difference in transfusion requirements was found.'5 An update of the spontaneous reporting of adverse reactions in the United Kingdom also suggested that adverse reactions to NSAIDs are more likely to be fatal in older patients. 6 In two studies of the relation between NSAID use and life threatening complications of peptic ulceration (bleeding or perforation) one study reported a striking difference in outcome,'3 but another could not confirm this. 7 It is difficult to conclude from our study whether the difference in outcome we found is merely a reflection of the patient's more advanced age, as differences in outcome existed for both the 60-79 age group and the over 80 age group but were only significant for the patient population as a whole (Table  V) . Nothing can be reported for younger patients in our study because of the relatively small number of patients in these age groups and the absence of fatal cases. In most studies, as in ours, there was no clear difference in the risk associated with a particular NSAID.467`8 There was also no clear relation between duration of intake and occurrence of bleeding, as is the case in most studies.2 Finally, it is not known whether NSAID associated ulcers are caused entirely by NSAIDs or represent an exacerbation by NSAIDs of pre-existing ulcers, or of an underlying 'peptic diathesis'.2 Our finding that the characteristics of bleeding ulcers associated with NSAID use (as regards the presence of symptoms ofpeptic ulcer disease and the multiplicity of lesions) are not different from those not associated with NSAID use is a relative argument in favour ofthe hypothesis that there is no fundamental difference between ulcers associated with NSAIDs and those not associated with NSAIDs. Another smaller study has already found no significant difference concerning symptoms of peptic ulcer disease in patients with NSAID or aspirin associated upper gastrointestinal bleeding. 6 Concerning aspirin use we could only find a significant difference between cases and control subjects for the whole population and for women, with no clear relation between dose or duration of intake. Our data are roughly in accordance with the findings of an earlier casecontrol study5 and confirm the conclusion that although the relation between aspirin use and upper gastrointestinal bleeding certainly exists, aspirin is of lesser importance than NSAID. ' There was no significant difference in the use of other drugs, paracetamol and corticosteroids in particular. Only one case-control study found an association between upper gastrointestinal bleeding and recent, but not longterm paracetamol exposure3; others found no association at all. Our finding of the highly significant association of upper gastrointestinal bleeding with the presence of peptic ulcer disease confirm the notion that symptoms ofpeptic ulcer disease are a risk factor for the development of peptic ulcer disease complications, in non-NSAID users as well as in NSAID-users.2 Nevertheless, among the 140 patients with bleeding peptic ulcer(s), bleeding was the first sign of peptic ulcer disease in 69 (52 2%); the absence of signs of peptic ulcer disease in a high proportion of patients with peptic ulcer complications has been reported repeatedly in recent years. 13 Finally, the attributable risk we found for NSAID use is somewhat higher than the figure reported by Somerville and colleagues,4 but the confidence intervals overlap; the attributable risk for aspirin in our study was nearly identical to the one reported by the same group.5 When we take into account that some patients were using NSAIDs and aspirin, our data are in accordance with the view that over one third of all haemorrhages from peptic ulcers can be attributed to NSAID or aspirin use. ' Some issues that concern the validity of our study should be discussed. In the participating hospitals a very high proportion of eligible subjects was included. We wish to mention, however, that the five participating hospitals cover only about half of the population of Antwerp; our data cannot be interpreted as being representative of the patient population of the whole city area. Another issue concerns the selection of control subjects. We went to great lengths to ascertain that the hospital control subjects were relevant, as stated above, and we believe that our control group was a well matched group. We have, however, not used community controls; this implies that some of our results should be interpreted with caution, particularly those concerning alcohol and tobacco use. Finally, our inclusion of patients with peptic oesophagitis and gastric erosions in the study can be criticised. We decided to include these patients because NSAIDs have been linked to peptic oesophagitis21 and because of the well known effect of aspirin (and, to a lesser extent, NSAIDs) to induce mucosal erosions by local irritation.2 For gastric erosions we found high odds ratios for both NSAIDs and aspirin, but the associations were not significant, probably because of the small number of patients with bleeding at this site. For oesophagitis odds ratios were low and not significant. It should be reiterated that the number of patients with two of these diagnoses was small; their inclusion in the patient population does not change any of the overall conclusions of the study.
We conclude that, in our study, NSAID use and the presence of symptoms of peptic ulcer disease were the major factors associated with upper gastrointestinal bleeding from 'erosive' lesions. We and others467 found a high relative risk for NSAID use, but it should be noted that the absolute individual risk is probably low.' Nevertheless, as pointed out, the number of cases induced in the whole population becomes important in view of the widespread use of NSAIDs. 24 We are indebted to Leon Kaufman for his help in the statistical analysis of the study.
